In his report made on September 30, 2004, Iraq Survey Group (ISG) leader Charles Duelfer reported: ” ‘[B]etween 1991 and 1996 Iraq possessed an expanding BW [biological weapons] agent production capability. From 1996 to OIF [Operation Iraqi Freedom] [March 20, 2003], Iraq still possessed small but significant dual-use facilities capable of conversion to small-scale BW agent production. ISG has found no evidence that Iraq used this capability for BW production.’ ”
– Douglas Feith, War and Decision, Page 226